Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Project #78: Mechanisms and Delivery of FGF19 in Type 1 Diabetes

    Forecasted

    Project #78: Mechanisms and Delivery of FGF19 in Type 1 Diabetes supports Armando Puente’s research on delivering FGF15 to beta cells to test whether it can prevent or delay type 1 diabetes in mice.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Project #83: CD318 orchestrates immune regulation and supports beta-cell function in T1D

    Project #83: CD318 orchestrates immune regulation and supports beta-cell function in T1D supports Jay Do’s research on CD138 to explore beta-cell protection and reduced inflammation in type 1 diabetes.

    DRCForecasted Jul 31, 2027$75,000Forecasted

    Project #80: Nano-in-microgel long-acting combination drug delivery platform for localized immunomodulation to prevent allogenic islet graft immune rejection in extrahepatic transplantation sites

    Project #80 supports Dr. Dhanashree Surve’s research on localized combination drug delivery to protect transplanted islet cells from immune rejection and reduce reliance on lifelong immunosuppression.

    DRCForecasted Jul 31, 2027$75,000Forecasted

    Project #77: Protection Against Type 1 Diabetes Development by mTOR/4E-BP2 Signaling

    This grant funds research on how mTOR/4E-BP2 signaling controls immune responses to prevent or delay type 1 diabetes, supporting discovery of new molecular targets and therapies.

    DRCForecasted May 1, 2027$75,000Forecasted

    Project #81: Exploring the Therapeutic Potential of a Novel IRE1 Inhibitor in Type 1 Diabetes

    Project #81: Exploring the Therapeutic Potential of a Novel IRE1 Inhibitor in Type 1 Diabetes supports Luka Suzuki's PAIR2 research to protect beta cells and improve blood-sugar control.

    DRCForecasted Jul 31, 2027$75,000Forecasted

    Leveraging NAMs to understand disease triggers, discover early biomarkers and develop new classes of therapeutic strategies for Type 1 Diabetes (U01 Clinical Trial Not Allowed)

    Supports research using human-relevant models to uncover early Type 1 diabetes triggers, identify biomarkers and therapeutic targets, and develop prevention strategies; clinical trials are not allowed.

    HHS-NIH11Forecasted Feb 10, 2027Forecasted